Syros Pharmaceuticals, Inc.
Q1 2025 13F Holders
Symbol
SYRS
CUSIP
87184Q206
Type
Equity
Class
COM NEW
Num filers
7
Total reported value, excl. options
$12.4k
Compare 2025 Q1 to
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
2022 Q4
2022 Q3
Excl. options
Options only
All
Manager
Report Date
Value ($000)
Shares
Option Type